(Q37658883)

21 August 2017

1 reference

title

Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza (English)

1 reference

21 August 2017

main subject

foot-and-mouth disease

1 reference

based on heuristic

inferred from title

classical swine fever

1 reference

2

Satya Parida

1 reference

21 August 2017

Ase Uttenthal

1

1 reference

21 August 2017

Thomas B Rasmussen

3

1 reference

21 August 2017

David J Paton

4

1 reference

21 August 2017

Bernd Haas

5

1 reference

21 August 2017

William G Dundon

6

1 reference

21 August 2017

language of work or name

1 reference

1 January 2010

1 reference

Expert Review of Vaccines

21 August 2017

published in

1 reference

21 August 2017

volume

9

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

73-87

1 reference

Diva vaccines that reduce virus transmission

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Application of DIVA vaccines and their companion diagnostic tests to foreign animal disease eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Overview of avian influenza DIVA test strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Novel marker vaccines against classical swine fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Vaccination against foot-and-mouth disease virus: strategies and effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Surveillance of FMD virus non-structural protein antibodies in pig populations involved in an eradication programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Developments in diagnostic techniques for differentiating infection from vaccination in foot-and-mouth disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Chimeric tymovirus-like particles displaying foot-and-mouth disease virus non-structural protein epitopes and its use for detection of FMDV-NSP antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Improvement of a serodiagnostic strategy for foot-and-mouth disease virus surveillance in cattle under systematic vaccination: a combined system of an indirect ELISA-3ABC with an enzyme-linked immunoelectrotransfer blot assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Development and use of a biotinylated 3ABC recombinant protein in a solid-phase competitive ELISA for the detection of antibodies against foot-and-mouth disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Multiplexed detection of antibodies to nonstructural proteins of foot-and-mouth disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Use of a standardized bovine serum panel to evaluate a multiplexed nonstructural protein antibody assay for serological surveillance of foot-and-mouth disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Secretory IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Demonstrating freedom from disease using multiple complex data sources 1: a new methodology based on scenario trees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

A review on classical swine fever infections in pigs: epizootiology, clinical disease and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Attenuated lapinized chinese strain of classical swine fever virus: complete nucleotide sequence and character of 3'-noncoding region

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Oral immunisation against classical swine fever (CSF): onset and duration of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

An experimental infection with classical swine fever in E2 sub-unit marker-vaccine vaccinated and in non-vaccinated pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Protection of pigs against ‘in contact’ challenge with classical swine fever following oral or subcutaneous vaccination with a recombinant porcine adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Comparison of antibody values in sera of pigs vaccinated with a subunit or an attenuated vaccine against classical swine fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Secreted expression of the classical swine fever virus glycoprotein E(rns) in yeast and application to a sandwich blocking ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Classical swine fever (CSF) marker vaccine. Trial II. Challenge study in pregnant sows.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Classical swine fever (CSF) marker vaccine. Trial III. Evaluation of discriminatory ELISAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Protection of pigs against classical swine fever with DNA-delivered gp55.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Porcine interleukin-3 enhances DNA vaccination against classical swine fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Virulence, immunogenicity and vaccine properties of a novel chimeric pestivirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Spying the neutralizing epitopes on E2 N-terminal by candidate epitope-vaccines against classical swine fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Candidate peptide-vaccine induced potent protection against CSFV and identified a principal sequential neutralizing determinant on E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

The development of an international reference panel of monoclonal antibodies for the differentiation of hog cholera virus from other pestiviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Deletions of structural glycoprotein E2 of classical swine fever virus strain alfort/187 resolve a linear epitope of monoclonal antibody WH303 and the minimal N-terminal domain essential for binding immunoglobulin G antibodies of a pig hyperimmune s

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Identification of a novel virulence determinant within the E2 structural glycoprotein of classical swine fever virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Mutation of E1 glycoprotein of classical swine fever virus affects viral virulence in swine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Development of a live attenuated antigenic marker classical swine fever vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Immunological properties of recombinant classical swine fever virus NS3 protein in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

A multiplex nested RT-PCR for the detection and differentiation of wild-type viruses from C-strain vaccine of classical swine fever virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Differentiation of C-strain "Riems" or CP7_E2alf vaccinated animals from animals infected by classical swine fever virus field strains using real-time RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Two real-time RT-PCR assays of classical swine fever virus, developed for the genetic differentiation of naturally infected from vaccinated wild boars.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

The biology of influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Increased resistance of vaccinated turkeys to experimental infection with an H7N3 low-pathogenicity avian influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Novel use of a N2-specific enzyme-linked immunosorbent assay for differentiation of infected from vaccinated animals (DIVA)-based identification of avian influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Progressive truncation of the Non-Structural 1 gene of H7N1 avian influenza viruses following extensive circulation in poultry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Appearance of serum antibodies against the avian influenza nonstructural 1 protein in experimentally infected chickens and turkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Development of an M2e-specific enzyme-linked immunosorbent assay for differentiating infected from vaccinated animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Development and use of fowlpox vectored vaccines for avian influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Recombinant Paramyxovirus Type 1-Avian Influenza-H7 Virus as a Vaccine for Protection of Chickens Against Influenza and Newcastle Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Assessment of the protection afforded by triple baculovirus recombinant coexpressing H5, N3, M1 proteins against a homologous H5N3 low-pathogenicity avian influenza virus challenge in Muscovy ducks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Detection of antibodies to the nonstructural protein (NS1) of avian influenza viruses allows distinction between vaccinated and infected chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Development and validation of an anti-N3 indirect immunofluorescent antibody test to be used as a companion diagnostic test in the framework of a “DIVA” vaccination strategy for avian influenza infections in poultry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.130

21 January 2018

Identifiers

DOI

10.1586/ERV.09.130

1 reference

21 August 2017

1 reference